查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595095

骨科生物製劑市場：按類型、應用和最終用戶分類 - 全球預測 2025-2030

Orthobiologics Market by Type (Allografts, Bone Morphogenic Proteins, Demineralised Bone Matrix), Application (Fracture Recovery, Reconstructive Surgery, Soft-Tissue Injuries), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，骨科生物製品市場價值為66.1億美元，預計到2024年將達到70.5億美元，複合年成長率為6.73%，到2030年將達到104.3億美元。

骨生物製品使用生物物質來幫助治癒肌肉骨骼損傷和病症，利用生長因子、蛋白質和幹細胞等天然成分來促進復原。該領域主要應用於整形外科和運動醫學領域，包括旨在增強身體自然癒合過程的產品。對骨科生物製劑的需求源於對微創治療的需求不斷成長，這些治療可以提供更快的恢復和更好的治療結果，特別是隨著人口老化和骨相關疾病的增加。生技藥品包括骨移植、脊椎融合和軟骨再生，最終用戶包括醫院、專科診所和門診手術中心。

主要市場統計
基準年[2023] 66.1億美元
預測年份 [2024] 70.5億美元
預測年份 [2030] 104.3億美元
複合年成長率（%） 6.73%

市場成長是由技術進步、研發投資增加以及越來越多的患者更喜歡新的再生療法而不是傳統方法推動的。生物技術在醫療保健領域的整合帶來了巨大的商機。特別是，幹細胞研究和生物材料工程的創新為產品開發帶來了突破性的潛力。然而，市場擴張面臨高成本、監管障礙和倫理考量等挑戰，特別是在幹細胞的使用方面。生技藥品製造的複雜性，加上嚴格的核准流程，為進入和產品開發帶來了巨大的障礙。

公司有很大的機會透過專注於個人化醫療的創新技術來增強產品系列，並開發具有成本效益和可擴展的生產方法。投資與學術機構的合作夥伴關係並利用政府資助的研究計劃可以加快產品開發和核准時間。創新的關鍵領域包括改進的遞送機制、提高的生物有效性和擴大的適應症。市場的動態本質以技術的快速進步和不斷變化的監管標準為特徵，因此需要靈活的策略規劃。公司專注於策略主導的研究，以有效地應對監管環境，並投資於教育計劃，以提高人們對市場環境的好處和應用的認知，最終推動市場需求。

市場動態：揭示快速發展的骨科生物製劑市場的關鍵市場洞察

供需的動態交互作用正在改變骨科生物製品市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球老年人口迅速增加，易患各種疾病
    • 人們對骨科生物學的認知不斷增強
    • 肥胖迅速增加，運動和交通事故增加
  • 市場限制因素
    • 骨科生物製劑價格上漲
  • 市場機會
    • 開發中國家的高成長潛力
    • 對先進治療的需求不斷增加
  • 市場挑戰
    • 嚴格的核准流程

波特的五力：駕馭骨科生物製劑市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解骨科生物製劑市場的外部影響

外部宏觀環境因素在塑造骨科生物製品市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解骨科生物製品市場的競爭格局

對骨科生物製品市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV 定位矩陣骨科生物製品市場供應商的績效評估

FPNV 定位矩陣是評估骨科生物製劑市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃骨科生物製品市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對骨科生物製品市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球範圍內易患各種疾病的老年人口正在迅速增加。
      • 提高對骨科生物學的認知
      • 肥胖迅速增加，運動和交通事故增加
    • 抑制因素
      • 骨科生物製劑價格昂貴
    • 機會
      • 開發中國家的高成長潛力
      • 對先進治療的需求不斷成長
    • 任務
      • 嚴格的核准流程
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章骨科生物製劑市場：依類型

  • 同種異體移植
  • 骨形成蛋白
  • 去礦骨基質
  • 滑液療法
  • 軟組織修復
  • 幹細胞療法
  • 人工骨移植

第7章骨科生物製品市場：依應用分類

  • 骨折恢復
  • 重組手術
  • 軟組織損傷
  • 脊椎融合手術
  • 創傷修復

第8章骨科生物製品市場：依最終使用者分類

  • 牙科診所和設施
  • 醫院
  • 研究/學術機構

第9章美洲骨科生物製品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區骨科生物製品市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的骨科生物製品市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Arthrex, Inc.
  • Bioventus LLC
  • DePuy Synthes
  • Globus Medical, Inc.
  • Harvest Technologies Corporation
  • Kuros Biosciences Ltd.
  • Nuvasive, Inc.
  • Orthofix International NV
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-036C5CF3B4C3

The Orthobiologics Market was valued at USD 6.61 billion in 2023, expected to reach USD 7.05 billion in 2024, and is projected to grow at a CAGR of 6.73%, to USD 10.43 billion by 2030.

Orthobiologics involves the use of biological substances to aid in the healing of musculoskeletal injuries and conditions, harnessing natural components such as growth factors, proteins, and stem cells to facilitate recovery. This sector encompasses products designed to enhance the body's innate healing processes, with applications primarily in orthopedic and sports medicine contexts. The necessity of orthobiologics arises from the growing demand for minimally invasive treatments that offer quicker recovery and improved outcomes, particularly with aging populations and increasing incidences of bone-related disorders. These biologics are applied in scenarios such as bone grafting, spinal fusion, and cartilage regeneration, with end users spanning hospitals, specialty clinics, and ambulatory surgical centers.

KEY MARKET STATISTICS
Base Year [2023] USD 6.61 billion
Estimated Year [2024] USD 7.05 billion
Forecast Year [2030] USD 10.43 billion
CAGR (%) 6.73%

Market growth is driven by advances in technology, increased investment in R&D, and a heightened patient preference for novel regenerative therapies over traditional methods. The integration of biotechnology in healthcare has opened substantial opportunities; particularly, innovations in stem cell research and biomaterial engineering are potential groundbreakers for product development. However, market expansion faces challenges including high costs, regulatory hurdles, and ethical considerations, notably concerning stem cell usage. The complexity of biologics production, coupled with stringent approval processes, presents significant barriers to entry and product development.

For businesses, significant opportunities lie in enhancing product portfolios with innovations focused on personalized medicine and developing cost-effective and scalable production methods. Investing in partnerships with academic institutions and leveraging government-funded research projects can accelerate product development and approval times. Key areas of innovation include improving delivery mechanisms, enhancing bioavailability, and expanding indications for use. The market's dynamic nature is characterized by rapid technological advancements and evolving regulatory standards, necessitating agility in strategic planning. Companies should focus on strategy-driven research to navigate regulatory landscapes efficiently and invest in educational initiatives that raise awareness of the benefits and applications of orthobiologics, ultimately driving market demand.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Orthobiologics Market

The Orthobiologics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Surge in geriatric population across the globe prone with various diseases
    • Increase in awareness of orthobiologics
    • Surge in obesity and rise in number of sports accidents and road accidents
  • Market Restraints
    • Higher cost of orthobiologics
  • Market Opportunities
    • High growth potential in developing nations
    • Upsurge in demand for advanced treatment
  • Market Challenges
    • Stringent approval process

Porter's Five Forces: A Strategic Tool for Navigating the Orthobiologics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Orthobiologics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Orthobiologics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Orthobiologics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Orthobiologics Market

A detailed market share analysis in the Orthobiologics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Orthobiologics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Orthobiologics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Orthobiologics Market

A strategic analysis of the Orthobiologics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Orthobiologics Market, highlighting leading vendors and their innovative profiles. These include Arthrex, Inc., Bioventus LLC, DePuy Synthes, Globus Medical, Inc., Harvest Technologies Corporation, Kuros Biosciences Ltd., Nuvasive, Inc., Orthofix International N.V., Stryker Corporation, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Orthobiologics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Allografts, Bone Morphogenic Proteins, Demineralised Bone Matrix, Joint Fluid Therapy, Soft Tissue Repair, Stem Cell Therapies, and Synthetic Bone Grafts.
  • Based on Application, market is studied across Fracture Recovery, Reconstructive Surgery, Soft-Tissue Injuries, Spinal Fusion, and Trauma Repair.
  • Based on End-User, market is studied across Dental Clinics & Facilities, Hospitals, and Research & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surge in geriatric population across the globe prone with various diseases
      • 5.1.1.2. Increase in awareness of orthobiologics
      • 5.1.1.3. Surge in obesity and rise in number of sports accidents and road accidents
    • 5.1.2. Restraints
      • 5.1.2.1. Higher cost of orthobiologics
    • 5.1.3. Opportunities
      • 5.1.3.1. High growth potential in developing nations
      • 5.1.3.2. Upsurge in demand for advanced treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent approval process
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Orthobiologics Market, by Type

  • 6.1. Introduction
  • 6.2. Allografts
  • 6.3. Bone Morphogenic Proteins
  • 6.4. Demineralised Bone Matrix
  • 6.5. Joint Fluid Therapy
  • 6.6. Soft Tissue Repair
  • 6.7. Stem Cell Therapies
  • 6.8. Synthetic Bone Grafts

7. Orthobiologics Market, by Application

  • 7.1. Introduction
  • 7.2. Fracture Recovery
  • 7.3. Reconstructive Surgery
  • 7.4. Soft-Tissue Injuries
  • 7.5. Spinal Fusion
  • 7.6. Trauma Repair

8. Orthobiologics Market, by End-User

  • 8.1. Introduction
  • 8.2. Dental Clinics & Facilities
  • 8.3. Hospitals
  • 8.4. Research & Academic Institutes

9. Americas Orthobiologics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Orthobiologics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Orthobiologics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Arthrex, Inc.
  • 2. Bioventus LLC
  • 3. DePuy Synthes
  • 4. Globus Medical, Inc.
  • 5. Harvest Technologies Corporation
  • 6. Kuros Biosciences Ltd.
  • 7. Nuvasive, Inc.
  • 8. Orthofix International N.V.
  • 9. Stryker Corporation
  • 10. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. ORTHOBIOLOGICS MARKET RESEARCH PROCESS
  • FIGURE 2. ORTHOBIOLOGICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ORTHOBIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ORTHOBIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ORTHOBIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ORTHOBIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ORTHOBIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ORTHOBIOLOGICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ORTHOBIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ORTHOBIOLOGICS MARKET DYNAMICS
  • TABLE 7. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENIC PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY DEMINERALISED BONE MATRIX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY JOINT FLUID THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY SOFT TISSUE REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY STEM CELL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY FRACTURE RECOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY SOFT-TISSUE INJURIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY TRAUMA REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY DENTAL CLINICS & FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES ORTHOBIOLOGICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. ORTHOBIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 153. ORTHOBIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023